A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine.
about
Adjuvant effect of caffeine on acetylsalicylic acid anti-nociception: prostaglandin E2 synthesis determination in carrageenan-induced peripheral inflammation in ratCombined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?Treatment of menstrual migraine: utility of control of related mood disturbances.Drug safety in acute migraine treatment.Comparison of analgesic effects of nimesulide, paracetamol, and their combination in animal models.A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned.
P2860
A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A safety assessment of fixed c ...... d, coformulated with caffeine.
@ast
A safety assessment of fixed c ...... d, coformulated with caffeine.
@en
A safety assessment of fixed c ...... d, coformulated with caffeine.
@nl
type
label
A safety assessment of fixed c ...... d, coformulated with caffeine.
@ast
A safety assessment of fixed c ...... d, coformulated with caffeine.
@en
A safety assessment of fixed c ...... d, coformulated with caffeine.
@nl
prefLabel
A safety assessment of fixed c ...... d, coformulated with caffeine.
@ast
A safety assessment of fixed c ...... d, coformulated with caffeine.
@en
A safety assessment of fixed c ...... d, coformulated with caffeine.
@nl
P2093
P2860
P1433
P1476
A safety assessment of fixed c ...... id, coformulated with caffeine
@en
P2093
G Williams
P Michielsen
W O Berndt
P2860
P304
P356
10.3109/08860229809045173
P577
1998-11-01T00:00:00Z